The Olive Oil Monophenolic Secoiridoid Ligstroside Aglycone Suppresses Melanoma Progression by Targeting the BRAF Signaling Pathway

Melanoma is among the most abundant malignancies in the US and worldwide. Ligstroside aglycone (LA) is a rare extra-virgin olive oil-derived monophenolic secoiridoid with diverse bioactivities. LA dose–response screening at the NCI 60 cancer cells panel identified the high sensitivity of the Malme-3...

Full description

Saved in:
Bibliographic Details
Main Authors: Md Ashiq Mahmud, Abu Bakar Siddique, Afsana Tajmim, Judy Ann King, Khalid A. El Sayed
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/30/1/139
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841549050672840704
author Md Ashiq Mahmud
Abu Bakar Siddique
Afsana Tajmim
Judy Ann King
Khalid A. El Sayed
author_facet Md Ashiq Mahmud
Abu Bakar Siddique
Afsana Tajmim
Judy Ann King
Khalid A. El Sayed
author_sort Md Ashiq Mahmud
collection DOAJ
description Melanoma is among the most abundant malignancies in the US and worldwide. Ligstroside aglycone (LA) is a rare extra-virgin olive oil-derived monophenolic secoiridoid with diverse bioactivities. LA dose–response screening at the NCI 60 cancer cells panel identified the high sensitivity of the Malme-3M cell line, which harbors a <i>BRAF V600E</i> mutation. Daily oral 10 mg/kg LA exhibited potent in vivo antitumor effects against Malme-3M cells xenograft in a nude mouse model by targeting the BRAF signaling pathway. A human Clariom S microarray analysis of the collected Malme- 3M tumors identified 571 dysregulated genes, with the downregulation of pathways critical for melanoma cells growth and survival. A Western blot analysis of the collected animal tumors further validated the downregulation of the mutated BRAF–MAPK axis, as well as the GPD1 and ELOVL6 expression levels. A histopathological analysis of Malme-3M tumor sections showed extensive focal tumor necrosis in treated mice. An immunofluorescence study of tumor sections showed notable reductions in proliferation marker ki67 and the vasculogenesis marker CD31 in treated tumors. These findings promote LA as a potential nutraceutical lead for the control of the <i>BRAF V600E</i> mutant melanoma.
format Article
id doaj-art-24784159cf804eb5af4f8096cbf5438d
institution Kabale University
issn 1420-3049
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj-art-24784159cf804eb5af4f8096cbf5438d2025-01-10T13:18:59ZengMDPI AGMolecules1420-30492025-01-0130113910.3390/molecules30010139The Olive Oil Monophenolic Secoiridoid Ligstroside Aglycone Suppresses Melanoma Progression by Targeting the BRAF Signaling PathwayMd Ashiq Mahmud0Abu Bakar Siddique1Afsana Tajmim2Judy Ann King3Khalid A. El Sayed4Department of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana at Monroe, 1800 Bienville Drive, Monroe, LA 71201, USADepartment of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana at Monroe, 1800 Bienville Drive, Monroe, LA 71201, USADepartment of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana at Monroe, 1800 Bienville Drive, Monroe, LA 71201, USAFoundational and Clinical Sciences Department, Thomas F. Frist, Jr. College of Medicine, Belmont University, 1900 Belmont Boulevard, Nashville, TN 37212, USADepartment of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana at Monroe, 1800 Bienville Drive, Monroe, LA 71201, USAMelanoma is among the most abundant malignancies in the US and worldwide. Ligstroside aglycone (LA) is a rare extra-virgin olive oil-derived monophenolic secoiridoid with diverse bioactivities. LA dose–response screening at the NCI 60 cancer cells panel identified the high sensitivity of the Malme-3M cell line, which harbors a <i>BRAF V600E</i> mutation. Daily oral 10 mg/kg LA exhibited potent in vivo antitumor effects against Malme-3M cells xenograft in a nude mouse model by targeting the BRAF signaling pathway. A human Clariom S microarray analysis of the collected Malme- 3M tumors identified 571 dysregulated genes, with the downregulation of pathways critical for melanoma cells growth and survival. A Western blot analysis of the collected animal tumors further validated the downregulation of the mutated BRAF–MAPK axis, as well as the GPD1 and ELOVL6 expression levels. A histopathological analysis of Malme-3M tumor sections showed extensive focal tumor necrosis in treated mice. An immunofluorescence study of tumor sections showed notable reductions in proliferation marker ki67 and the vasculogenesis marker CD31 in treated tumors. These findings promote LA as a potential nutraceutical lead for the control of the <i>BRAF V600E</i> mutant melanoma.https://www.mdpi.com/1420-3049/30/1/139<i>BRAF V600E</i> mutationELOVL6GPD1ligstroside aglyconemelanomaolive phenolics
spellingShingle Md Ashiq Mahmud
Abu Bakar Siddique
Afsana Tajmim
Judy Ann King
Khalid A. El Sayed
The Olive Oil Monophenolic Secoiridoid Ligstroside Aglycone Suppresses Melanoma Progression by Targeting the BRAF Signaling Pathway
Molecules
<i>BRAF V600E</i> mutation
ELOVL6
GPD1
ligstroside aglycone
melanoma
olive phenolics
title The Olive Oil Monophenolic Secoiridoid Ligstroside Aglycone Suppresses Melanoma Progression by Targeting the BRAF Signaling Pathway
title_full The Olive Oil Monophenolic Secoiridoid Ligstroside Aglycone Suppresses Melanoma Progression by Targeting the BRAF Signaling Pathway
title_fullStr The Olive Oil Monophenolic Secoiridoid Ligstroside Aglycone Suppresses Melanoma Progression by Targeting the BRAF Signaling Pathway
title_full_unstemmed The Olive Oil Monophenolic Secoiridoid Ligstroside Aglycone Suppresses Melanoma Progression by Targeting the BRAF Signaling Pathway
title_short The Olive Oil Monophenolic Secoiridoid Ligstroside Aglycone Suppresses Melanoma Progression by Targeting the BRAF Signaling Pathway
title_sort olive oil monophenolic secoiridoid ligstroside aglycone suppresses melanoma progression by targeting the braf signaling pathway
topic <i>BRAF V600E</i> mutation
ELOVL6
GPD1
ligstroside aglycone
melanoma
olive phenolics
url https://www.mdpi.com/1420-3049/30/1/139
work_keys_str_mv AT mdashiqmahmud theoliveoilmonophenolicsecoiridoidligstrosideaglyconesuppressesmelanomaprogressionbytargetingthebrafsignalingpathway
AT abubakarsiddique theoliveoilmonophenolicsecoiridoidligstrosideaglyconesuppressesmelanomaprogressionbytargetingthebrafsignalingpathway
AT afsanatajmim theoliveoilmonophenolicsecoiridoidligstrosideaglyconesuppressesmelanomaprogressionbytargetingthebrafsignalingpathway
AT judyannking theoliveoilmonophenolicsecoiridoidligstrosideaglyconesuppressesmelanomaprogressionbytargetingthebrafsignalingpathway
AT khalidaelsayed theoliveoilmonophenolicsecoiridoidligstrosideaglyconesuppressesmelanomaprogressionbytargetingthebrafsignalingpathway
AT mdashiqmahmud oliveoilmonophenolicsecoiridoidligstrosideaglyconesuppressesmelanomaprogressionbytargetingthebrafsignalingpathway
AT abubakarsiddique oliveoilmonophenolicsecoiridoidligstrosideaglyconesuppressesmelanomaprogressionbytargetingthebrafsignalingpathway
AT afsanatajmim oliveoilmonophenolicsecoiridoidligstrosideaglyconesuppressesmelanomaprogressionbytargetingthebrafsignalingpathway
AT judyannking oliveoilmonophenolicsecoiridoidligstrosideaglyconesuppressesmelanomaprogressionbytargetingthebrafsignalingpathway
AT khalidaelsayed oliveoilmonophenolicsecoiridoidligstrosideaglyconesuppressesmelanomaprogressionbytargetingthebrafsignalingpathway